X0306 4 2014-09-19 0 0001419554 Bone Biologics Corp NONE 0001655452 SOO B CHIA C/O BONE BIOLOGICS CORPORATION 321 COLUMBUS AVENUE BOSTON MA 02116 1 0 0 0 Common Stock 2014-09-19 4 J 0 1000000 A 1000000 D Common Stock 2000000 I By Spouse Common Stock 2015-09-19 4 A 0 31646 0.00 A 1031646 D Common Stock 2015-10-09 4 S 0 52744 1.58 D 978902 D Common Stock 2015-10-22 5 G 0 E 2000000 0.00 D 0 I By Spouse Common Stock 2015-10-22 5 G 0 E 2000000 0.00 A 2978902 D Warrant (Right to Buy) 0.44 2014-09-19 4 J 0 119318 A 2024-09-19 Common Stock 119318 119318 D Common Stock (Right to Acquire) 0.00 2015-10-02 4 A 0 384615.33 0.00 A Common Stock 384615.33 384615.33 D Represents shares of Common Stock of the Issuer issued pursuant to that certain Agreement and Plan of Merger (the "Merger Agreement"), dated as of September 19, 2014 by and among AFH Acquisition X, Inc., Bone Biologics, Inc. and Bone Biologics Acquisition Corp. Pursuant to the terms of the Merger Agreement each share of Common Stock of Bone Biologics, Inc. was converted into the same number of shares of the Issuer's Common Stock. These shares are owned by Kang Ting. Dr. Ting is the spouse of the Reporting Person. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Does not include 384,615.33 shares of Common Stock issuable to Dr. Ting on the earlier of September 24, 2018 and the occurrence of certain events described in a letter agreement by and between the Issuer and the Reporting Person dated September 24, 2015 and attached as Exhibit 10.1 to Form 8-K filed with the Securities and Exchange Commission on October 8, 2015. These shares were acquired by the Reporting Person pursuant to Reporting Person's non-employee director offer letter with the Issuer. These shares were sold by the Reporting Person in a private transaction. This transaction involved a gift of the shares of Common Stock owned by Dr. Ting to the Reporting Person. On February 4, 2010, the Reporting Person acquired a warrant to purchase 119,318 shares of Common Stock of Bone Biologics, Inc.at an exercise price of $0.44 per share. Pursuant to the Merger Agreement, this warrant was converted into a warrant to purchase 119,318 shares of the Issuer's Common Stock at a per share exercise price of $0.44. The warrant is fully vested and exercisable. Immediately exercisable. Issuable to the Reporting Person on the earlier of September 24, 2018 and the occurrence of certain events described in a letter agreement by and between the Issuer and the Reporting Person dated September 24, 2015 and attached as Exhibit 10.1 to Form 8-K filed with the Securities and Exchange Commission on October 8, 2015. /s/Chia Soo 2015-12-18